IL149401A0 - 1-amino-alkylcyclohexane nmda receptor antagonists - Google Patents

1-amino-alkylcyclohexane nmda receptor antagonists

Info

Publication number
IL149401A0
IL149401A0 IL14940199A IL14940199A IL149401A0 IL 149401 A0 IL149401 A0 IL 149401A0 IL 14940199 A IL14940199 A IL 14940199A IL 14940199 A IL14940199 A IL 14940199A IL 149401 A0 IL149401 A0 IL 149401A0
Authority
IL
Israel
Prior art keywords
amino
receptor antagonists
nmda receptor
compounds
alleviation
Prior art date
Application number
IL14940199A
Other languages
English (en)
Original Assignee
Merz Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharmaceuticals Gmbh filed Critical Merz Pharmaceuticals Gmbh
Publication of IL149401A0 publication Critical patent/IL149401A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL14940199A 1999-11-01 1999-11-01 1-amino-alkylcyclohexane nmda receptor antagonists IL149401A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1999/008317 WO2001032640A1 (en) 1999-11-01 1999-11-01 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants

Publications (1)

Publication Number Publication Date
IL149401A0 true IL149401A0 (en) 2002-11-10

Family

ID=8167482

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14940199A IL149401A0 (en) 1999-11-01 1999-11-01 1-amino-alkylcyclohexane nmda receptor antagonists
IL149401A IL149401A (en) 1999-11-01 2002-04-29 1-amino-alkylcyclohexane NMDA receptor antagonists

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL149401A IL149401A (en) 1999-11-01 2002-04-29 1-amino-alkylcyclohexane NMDA receptor antagonists

Country Status (24)

Country Link
EP (1) EP1228052B1 (pl)
JP (1) JP4043236B2 (pl)
KR (1) KR100548600B1 (pl)
CN (1) CN1264827C (pl)
AT (1) ATE361284T1 (pl)
AU (1) AU782760B2 (pl)
CA (1) CA2389325C (pl)
CY (1) CY1106672T1 (pl)
CZ (1) CZ20021533A3 (pl)
DE (1) DE69936004T2 (pl)
DK (1) DK1228052T3 (pl)
EA (1) EA005684B1 (pl)
ES (1) ES2285870T3 (pl)
HK (1) HK1049160B (pl)
HU (1) HUP0203275A3 (pl)
IL (2) IL149401A0 (pl)
MX (1) MXPA02004368A (pl)
NO (1) NO322359B1 (pl)
PL (1) PL199587B1 (pl)
PT (1) PT1228052E (pl)
SI (1) SI1228052T1 (pl)
TW (1) TWI242547B (pl)
UA (1) UA72558C2 (pl)
WO (1) WO2001032640A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
PL2475428T3 (pl) 2009-09-11 2015-12-31 Probiodrug Ag Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
MX2012010470A (es) 2010-03-10 2012-10-09 Probiodrug Ag Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5).
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
CN104211663B (zh) * 2014-08-11 2017-01-11 杭州偶联医药科技有限公司 一种(s)-n-甲氧基-甲基-2-(四氢吡咯基)丙酰胺及其制备方法和应用
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej
RU2714135C1 (ru) * 2019-11-22 2020-02-12 Федеральное государственное бюджетное учреждение науки "Институт токсикологии Федерального медико-биологического агентства" Гидрохлорид (1-метилпиперидин-4-ил)-2-пропилпентаноата, обладающий холинолитической и противосудорожной активностью

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097207A (en) * 1958-03-06 1963-07-09 Parke Davis & Co 1-halophenyl and 1-alkoxyphenyl cyclohexylamines
UA61962C2 (uk) * 1997-06-30 2003-12-15 Мерц Фарма Гмбх Унд Ко. Кгаа Сполука 1-аміноалкілциклогексану, фармацевтична композиція на її основі та спосіб лікування

Also Published As

Publication number Publication date
ATE361284T1 (de) 2007-05-15
CN1264827C (zh) 2006-07-19
IL149401A (en) 2008-03-20
KR100548600B1 (ko) 2006-02-01
AU1158500A (en) 2001-05-14
AU782760B2 (en) 2005-08-25
JP4043236B2 (ja) 2008-02-06
NO20022044D0 (no) 2002-04-30
CZ20021533A3 (cs) 2002-08-14
NO322359B1 (no) 2006-09-18
EP1228052A1 (en) 2002-08-07
ES2285870T3 (es) 2007-11-16
PT1228052E (pt) 2007-05-31
EP1228052B1 (en) 2007-05-02
HUP0203275A2 (hu) 2003-01-28
DE69936004D1 (de) 2007-06-14
DE69936004T2 (de) 2008-01-10
PL354519A1 (pl) 2004-01-26
NO20022044L (no) 2002-04-30
HK1049160B (zh) 2006-11-17
CA2389325C (en) 2007-01-09
HUP0203275A3 (en) 2003-11-28
TWI242547B (en) 2005-11-01
PL199587B1 (pl) 2008-10-31
HK1049160A1 (en) 2003-05-02
EA005684B1 (ru) 2005-04-28
SI1228052T1 (sl) 2007-10-31
KR20020063172A (ko) 2002-08-01
EA200200522A1 (ru) 2002-10-31
JP2003513083A (ja) 2003-04-08
WO2001032640A1 (en) 2001-05-10
CY1106672T1 (el) 2012-05-23
MXPA02004368A (es) 2002-11-14
CA2389325A1 (en) 2001-05-10
DK1228052T3 (da) 2007-06-18
UA72558C2 (uk) 2005-03-15
CN1374956A (zh) 2002-10-16

Similar Documents

Publication Publication Date Title
CY1106672T1 (el) Ενωσεις 1-κυκλικου αμινο-αλκυλοκυκλοεξανιου, φαρμακευτικες συνθεσεις αυτων και η χρηση τους ως αντισπασμωδικα
EP1361220A4 (en) CYCLIC COMPOUNDS WITH THROMBOPOIETIN RECEPTAGONISM
ITMI922006A1 (it) Esteri nitrici di derivati dell'acido 2-(2, 6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
HU907660D0 (en) Process for producing tricyclic compounds and pharmaceutical preparatives containing such compounds as active substances
EP1207155A4 (en) DRUG COMPOSITIONS HAVING AGONIST THROMBOPOIETINE ACTIVITY
MXPA04003398A (es) Activador para el receptor o activado con el proliferador de peroxisoma.
EP1036794A4 (en) 2-ARYL-8-OXODIHYDROPURIN DERIVATIVES, THEIR PRODUCTION, THEIR USE AS MEDICINE COMPONENTS AND THEIR INTERMEDIATES
AU2337197A (en) Cinnamic acid derivatives and their use as integrin antagonists
WO2000010965A3 (en) Quaternary ammonium salts and their use as anti-hiv agents
MXPA04001258A (es) Activador para el receptor d que responde al proliferador de peroxisoma.
EP1019045A4 (en) ANTITHROMBOTIC AGENTS
EP0999834A4 (en) ANTITHROMOSIS
WO2005058884A3 (en) Cyclopropane compounds and pharmaceutical use thereof
TW341565B (en) Indole derivatives processes and intermediates for their preparation and pharmaceutical compositions containing them
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
NZ331060A (en) Quinoxalinediones, preparation and pharmaceutical compositions thereof
HUT65351A (en) Process for preparing ethanolamine derivatives haring sympathominetic and anti-pollakiuria activity and pharmaceutical compositions containing them as active agent
CA2336412A1 (en) Medicament for treatment of diabetes
AU672052B2 (en) Antidepressant and antiparkinsonian compounds
SI1233953T1 (en) Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same
CA2226886A1 (en) N-(4-substituted-benzyl)-2-aminolactam derivatives
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
CR20230218A (es) Nuevos derivados de indazol acetileno
AU3191293A (en) New naphthalene amides and sulphonamides, processes for their preparation and pharmaceutical compositions containing them
IL125982A0 (en) 2-(arylphenyl) amino-imidazoline derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed